Stockscreener 앱 받기
4.25
21.00%
-1.13
시간 외 거래:
4.29
0.04
+0.94%
전일 마감가:
$5.38
열려 있는:
$3.73
하루 거래량:
1.73M
Relative Volume:
5.18
시가총액:
$112.35M
수익:
$50.14M
순이익/손실:
$-35.38M
주가수익비율:
-3.0357
EPS:
-1.4
순현금흐름:
$-39.46M
1주 성능:
-17.64%
1개월 성능:
-24.24%
6개월 성능:
-51.04%
1년 성능:
-46.41%
1일 변동 폭
$3.60
$4.26
1주일 범위
$3.60
$5.64
52주 변동 폭
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
RCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.25 | 141.69M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
AVITA Medical CEO to Present Q2 Earnings Deep Dive: How to Join the Upcoming Investor Briefing - Stock Titan
Evernest Financial Advisors LLC Makes New Investment in Avita Medical Inc. (NASDAQ:RCEL) - MarketBeat
AVITA Medical (RCEL.O) Suffers 21% Drop: A Technical and Order-Flow Deep Dive - AInvest
AVITA Medical, Inc. (NASDAQ:RCEL) Not Doing Enough For Some Investors As Its Shares Slump 25% - simplywall.st
Avita Medical (NASDAQ:RCEL) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Avita Medical Inc. (NASDAQ:RCEL) Receives $13.60 Average Price Target from Analysts - MarketBeat
Avita projects $76M–$81M 2025 revenue with rebound expected as claims backlog eases - MSN
Lower fair value for undervalued ASX share - Morningstar
Avita Medical (NASDAQ:RCEL) Downgraded by BTIG Research to "Sell" - MarketBeat
Avita Medical Q2 2025 Revenue at $18.4M, Projects $76M-$81M 2025 Revenue with Backlog Easing - AInvest
D. Boral Capital Cuts Avita Medical (NASDAQ:RCEL) Price Target to $18.00 - MarketBeat
AVITA Medical 2025 Q2 Earnings Narrowed Losses, Revenues Up but Guidance Cut - AInvest
Avita Medical shares rise 2.82% after-hours after revising earnings guidance for 2025. - AInvest
Avita Medical: Navigating Short-Term Reimbursement Headwinds, Unlocking Long-Term Growth in Acute Wound Care - AInvest
Avita’s Road to Profitability Is in Sight - Morningstar
Form 424B5 AVITA Medical, Inc. - StreetInsider
BTIG Downgrades AVITA Medical to Sell From Neutral, Price Target is $3 - MarketScreener
Earnings call transcript: Avita Medical Q2 2025 reveals revenue miss, stock tumbles - Investing.com Canada
Avita Medical stock downgraded to Sell by BTIG on reimbursement issues - Investing.com Canada
AVITA Medical, Inc. SEC 10-Q Report - TradingView
Avita Medical shares fall 31.97% premarket after revising earnings guidance for 2025. - AInvest
Avita Medical Q2 2025 slides: revenue grows 21% but guidance slashed on reimbursement delays - Investing.com Canada
AVITA Medical Inc (AVHHL) Q2 2025 Earnings Call Highlights: Reve - GuruFocus
Transcript : AVITA Medical, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
AVITA Medical Reports Q2 2025 Financial Results - TipRanks
Avita Medical (RCEL) Q2 Sales Up 21% - The Motley Fool
Guess which ASX All Ords stock just crashed 23% on earnings miss - The Motley Fool Australia
Published on: 2025-08-08 05:19:09 - beatles.ru
Avita Medical earnings missed by $0.13, revenue fell short of estimates - Investing.com Canada
Avita Medical Amends Credit Agreement with OrbiMed - TipRanks
AVITA Medical Inc (RCEL) Q2 2025 Earnings: EPS of -$0.38 Misses Estimate, Revenue of $18.4M Falls Short - GuruFocus
RCEL cuts revenue covenants, issues 400k shares in credit amendment | PBYI SEC FilingForm 8-K - Stock Titan
RCEL cuts revenue covenants, issues 400k shares in credit amendment | RCEL SEC FilingForm 8-K - Stock Titan
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation - The Manila Times
Avita Medical Chair to Step Down, Successor Named - MarketScreener
Avita Medical Appoints Dr. Michael Tarnoff to Board - TipRanks
AVITA Medical Appoints Michael Tarnoff to Board, Lou Panaccio Steps Down, Cary Vance Assumes Chair Role - AInvest
Former Medtronic Executive and Tufts Medical Leader Joins AVITA Medical Board as Company Reshapes Leadership - Stock Titan
Avita Medical (RCEL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
AVITA Medical Inc. Stock Analysis and ForecastHigh-performance investment picks - Jammu Links News
How does AVITA Medical Inc. compare to its industry peersDiscover breakthrough investment opportunities - Jammu Links News
Published on: 2025-08-04 03:16:57 - Jammu Links News
Should I hold or sell AVITA Medical Inc. stock in 2025Boost your wealth with consistent growth stocks - Jammu Links News
What makes AVITA Medical Inc. stock price move sharplyConsistently high returns - Jammu Links News
What analysts say about AVITA Medical Inc. stockTurn market volatility into profit opportunities - Jammu Links News
How many analysts rate AVITA Medical Inc. as a “Buy”Free Trend-Following Techniques - Jammu Links News
How volatile is AVITA Medical Inc. stock compared to the marketFree Market Dynamics Reports - Jammu Links News
Visual trend scoring systems applied to AVITA Medical Inc.Safe Investment Ideas with Growth Upside - Newser
Is AVITA Medical Inc. stock bottoming outFree Daily Volume Spike Trading Signals - Newser
AVITA Medical Inc. stock chart pattern explainedRisk Aware Swing Trade Analysis Insights - Newser
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):